Skip to main content
PlainMeds

What the label lists and what reports show

Echothiophate side effects

Echothiophate's FDA label lists its adverse reactions in its own words. FAERS holds 146 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is intraocular pressure increased (27 reports).

  • No generic listed

Check it at the source: the echothiophate FDA label on DailyMed (effective July 7, 2025, Fera Pharmaceuticals, LLC); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

Although the relationship, if any, of retinal detachment to the administration of echothiophate iodide for ophthalmic solution has not been established, retinal detachment has been reported in a few cases during the use of echothiophate iodide for ophthalmic solution in adult patients without a previous history of this disorder. Stinging, burning, lacrimation, lid muscle twitching, conjunctival and ciliary redness, browache, induced myopia with visual blurring may occur. Activation of latent iritis or uveitis may occur. Iris cysts may form, and if treatment is continued, may enlarge and obscure vision. This occurrence is more frequent in children. The cysts usually shrink upon discontinuance of the medication or by reducing the frequency of instillation. Rarely, they may rupture or break free into the aqueous. …

Source: FDA drug label, Fera Pharmaceuticals, LLC, effective July 7, 2025 (SPL set 8afc8951-db76-4f27-8752-7c0d6aa47244), via openFDA; the full label on DailyMed

What do FAERS reports show?

146 reports list echothiophate among the medicines taken, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 5 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 20 reactions below, none is named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

The 25 most reported reactions

  • Intraocular Pressure Increased27
  • Drug Ineffective (a use or a product term, not a reaction)22
  • Visual Impairment17
  • Eye Pain13
  • Visual Acuity Reduced10
  • Blindness9
  • Blindness Unilateral8
  • Ocular Hyperaemia8
  • Eye Disorder7
  • Eye Irritation7
  • Vision Blurred7
  • Glaucoma6
  • Headache6
  • Product Quality Issue (a use or a product term, not a reaction)6
  • Malaise5
  • Eye Pruritus4
  • Illness4
  • Off Label Use (a use or a product term, not a reaction)4
  • Cataract3
  • Condition Aggravated (a use or a product term, not a reaction)3
  • Corneal Disorder3
  • Drug Dispensing Error3
  • Drug Hypersensitivity3
  • Expired Product Administered (a use or a product term, not a reaction)3
  • Hypoacusis3

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Echothiophate: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions